Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

Immuneering (IMRX) Non Operating Investment Income: 2021-2022

Historic Non Operating Investment Income for Immuneering (IMRX) over the last 2 years, with Dec 2022 value amounting to $18,889.

  • Immuneering's Non Operating Investment Income rose 353.86% to $112,353 in Q4 2022 from the same period last year, while for Dec 2022 it was $18,889, marking a year-over-year change of. This contributed to the annual value of $18,889 for FY2022, which is 138.54% up from last year.
  • As of FY2022, Immuneering's Non Operating Investment Income stood at $18,889, which was up 138.54% from -$49,009 recorded in FY2021.
  • Over the past 5 years, Immuneering's Non Operating Investment Income peaked at $18,889 during FY2022, and registered a low of -$49,009 during FY2021.
  • In the last 2 years, Immuneering's Non Operating Investment Income had a median value of -$15,060 in 2021 and averaged -$15,060.
  • Data for Immuneering's Non Operating Investment Income shows a peak YoY surged of 138.54% (in 2022) over the last 5 years.
  • Yearly analysis of 2 years shows Immuneering's Non Operating Investment Income stood at -$49,009 in 2021, then skyrocketed by 138.54% to $18,889 in 2022.